Cardiac sympathetic innervation and cardiac resynchronization therapy.

Area of Science:

• Cardiology
• Medical Imaging
• Nuclear Medicine

Background:

• Cardiac resynchronization therapy (CRT) is a crucial treatment for heart failure, reducing morbidity and mortality.
• Current CRT indications rely solely on QRS duration and heart failure functional class.
• A significant portion of patients do not respond to CRT, necessitating improved patient selection to optimize outcomes and minimize complications.

Purpose of the Study:

• To review the existing literature on the role of cardiac sympathetic innervation imaging in predicting CRT response.
• To explore the utility of (123)I-metaiodobenzylguanidine (MIBG) scintigraphy in patient selection for CRT.

Main Methods:

• Systematic review of studies investigating cardiac innervation scintigraphy in patients undergoing CRT.
• Analysis of 9 studies involving a total of 225 patients.
• Focus on (123)I-MIBG scintigraphy as a measure of cardiac sympathetic innervation.

Main Results:

• Cardiac sympathetic innervation patterns, assessed by (123)I-MIBG scintigraphy, show potential relevance in CRT.
• The reviewed studies suggest a link between cardiac innervation and CRT response, although further research is needed.
• This imaging technique may offer additional criteria for selecting patients who will benefit most from CRT.

Conclusions:

• Cardiac sympathetic innervation imaging, particularly with (123)I-MIBG, warrants further investigation as a tool to improve patient selection for CRT.
• Integrating innervation imaging could enhance CRT efficacy and reduce non-response rates in heart failure patients.
• Optimizing CRT patient selection is vital for improving therapeutic outcomes and minimizing associated costs and risks.